| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/03/2004 | US20040106668 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106582 carbo-or heterocycle-ethynyl-substituted pyridines or pyrimidines; e.g., 2-[2-(pyridine-3-yl)ethynyl]-6-methyl-pyridine |
| 06/03/2004 | US20040106574 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
| 06/03/2004 | US20040105900 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | US20040105798 Sterilizing tunnel for pharmaceutical containers |
| 06/03/2004 | DE10133305B4 Ubichinon Konzentrat Ubiquinone concentrate |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
| 06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1424081A1 Polysaccharide-containing compositions and use thereof |
| 06/02/2004 | EP1424062A1 Screening composition containing at least one dibenzoylmethane derivative and at least one 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one; photostabilisation process |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423515A1 Anti-aging and wound healing compounds |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423428A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423410A2 Peptides having a c-terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
| 06/02/2004 | EP1423407A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423388A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 06/02/2004 | EP1423382A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423375A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
| 06/02/2004 | EP1423154A2 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |
| 06/02/2004 | EP1423119A1 Heterobicycles fkbp-ligands |
| 06/02/2004 | EP1423117A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423082A2 Plasma protein matrices and methods for their preparation |
| 06/02/2004 | EP1326613B1 Use of substituted imidazo 1,2-a]pyridine-, imidazo [1,2-a]pyrimidine and imidazo [1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | EP0941105A4 Pretraumatic use of hemoglobin |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501814A Pharmaceutical compositions |
| 06/02/2004 | CN1501804A Acrochordon alleviation |
| 06/02/2004 | CN1501803A Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 06/02/2004 | CN1501797A Anti-proliferative drugs |
| 06/02/2004 | CN1500810A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500809A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500807A Method for diagnosing and curing alopecia utilizing the Rhor gene of human and rat and the encoding products |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500515A Formula of Chinese caterpillar fungus extract for stabilizing, regenerating and blackening hair, and its preparation method |
| 06/02/2004 | CN1500506A Hair regenerating formulation and its production method |
| 06/02/2004 | CN1500480A Use of composition containing undecylenic acid zinc in preparation of drug of curing underarm odour |
| 06/02/2004 | CN1500474A Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
| 06/02/2004 | CN1500472A Beauty liquid |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1152011C Vitamin D analogues and pharmaceutical uses thereof |
| 06/02/2004 | CN1151811C Pain-relieving compound notoginseng mixture formulation |
| 06/02/2004 | CN1151810C Face-beautifying face-nourishing capsule and preparation method |
| 06/02/2004 | CN1151805C Medicinal liquid for curing scald and burn |
| 06/02/2004 | CN1151804C Use of Whiteflower Leadword Root |
| 06/02/2004 | CN1151796C Remedy and preparation process of medicine for treating burns and scalds |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743858 Sealing polymerizable adhesive monomer and a thickening agent in a container and sterilizing with dry heat or radiation |
| 06/01/2004 | US6743822 Applying to area of skin a dermatologically acceptable composition comprising alpha -difluoromethylornithine in an amount effective to reduce hair growth |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743792 Antiinflammatory agents |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743433 Treatment of acne using alkanolamine compositions |